Jyong Biotech Ltd. MENS
2.03
(0.12)
(5.58%)
as of 25 Sep
- Market cap
- $162.6M
- P/E
- —
Follow MENS
| Dec '25 | Jun '25 | Dec '24 | Dec '23 | |
|---|---|---|---|---|
Current Ratio |
0.45 | 0.62 | 0.02 | 0.13 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
88.76% | 93.06% | 282.12% | 199.95% |
Debt/Equity |
(0.74) | (1.56) | (0.49) | (0.48) |
Operating CF/Net income |
0.00 | — | 0.00 | 0.00 |
Capex/Depreciation |
0.00 | — | 0.00 | 0.00 |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | — | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
(3.04) | — | (3.62) | (2.60) |
Working Capital |
(19.27) | (10.39) | (11.92) | (12.42) |
Capital Expenditures |
0.00 | — | 0.00 | 0.00 |
Net Current Asset Value |
(30.14) | (42.98) | (42.68) | (40.48) |
| Other line items | ||||
Quick Ratio |
0.03 | 0.62 | 0.01 | 0.12 |
Operating CF per Share |
0.00 | — | 0.00 | 0.00 |
Capex per Share |
0.00 | — | 0.00 | 0.00 |
Capex to Sales |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates